Tempest Therapeutics Inc.

0.66
-0.06 (-8.14%)
At close: Apr 04, 2025, 11:09 AM

Tempest Therapeutics Statistics

Share Statistics

Tempest Therapeutics has 45.48M shares outstanding. The number of shares has increased by 96.43% in one year.

Shares Outstanding 45.48M
Shares Change (YoY) 96.43%
Shares Change (QoQ) 0%
Owned by Institutions (%) 26.28%
Shares Floating 41.29M
Failed to Deliver (FTD) Shares 20.15K
FTD / Avg. Volume 2.48%

Short Selling Information

The latest short interest is 2.64M, so 6.04% of the outstanding shares have been sold short.

Short Interest 2.64M
Short % of Shares Out 6.04%
Short % of Float 6.66%
Short Ratio (days to cover) 0.39

Valuation Ratios

The PE ratio is -0.56 and the forward PE ratio is -0.82. Tempest Therapeutics's PEG ratio is 0.03.

PE Ratio -0.56
Forward PE -0.82
PS Ratio 0
Forward PS 0.3
PB Ratio 1.22
P/FCF Ratio -0.7
PEG Ratio 0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Tempest Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.8.

Current Ratio 2.21
Quick Ratio 2.21
Debt / Equity 0.8
Debt / EBITDA -
Debt / FCF -0.46
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.74M
Employee Count 24
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -41.84M
Effective Tax Rate 100%

Stock Price Statistics

The stock price has increased by -84% in the last 52 weeks. The beta is -2.28, so Tempest Therapeutics's price volatility has been lower than the market average.

Beta -2.28
52-Week Price Change -84%
50-Day Moving Average 0.85
200-Day Moving Average 1.2
Relative Strength Index (RSI) 36.73
Average Volume (20 Days) 813.17K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income 0
Net Income -41.84M
EBITDA 0
EBIT n/a
Earnings Per Share (EPS) -1.5
Full Income Statement

Balance Sheet

The company has 30.27M in cash and 15.37M in debt, giving a net cash position of 14.9M.

Cash & Cash Equivalents 30.27M
Total Debt 15.37M
Net Cash 14.9M
Retained Earnings -207.11M
Total Assets 41.49M
Working Capital 17.25M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -33.03M and capital expenditures -435K, giving a free cash flow of -33.46M.

Operating Cash Flow -33.03M
Capital Expenditures -435K
Free Cash Flow -33.46M
FCF Per Share -1.2
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TPST does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for TPST is $7, which is 872.2% higher than the current price. The consensus rating is "Buy".

Price Target $7
Price Target Difference 872.2%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Stock Splits

The last stock split was on Jun 28, 2021. It was a backward split with a ratio of 1:15.

Last Split Date Jun 28, 2021
Split Type backward
Split Ratio 1:15

Scores

Altman Z-Score -8.82
Piotroski F-Score 3